To define the long-term variability of serial coronary flow reserve (CFR) catheter and intracoronary papaverine. Initial CFR measurements were highly correlated with repeat measurements obtained 11±0.6 months later (r=0.95; mean absolute difference, 0.3±0.1; n=17). Differences in CFRbetween studies were related to changes in heart rate (r=0.61,p=0.01) but not to changes in mean arterial pressure (r=0.25, p=0.33). To define the effects of rapid changes in heart rate, mean arterial pressure, and preload on CFR, these variables were altered by atrial pacing, handgrip exercise, and volume expansion, respectively. Atrial pacing produced a rate-related increase in rCBFV but did not change hCBFV. Consequently, CFR was significantly reduced as heart rate was increased progressively from 76±2 in sinus rhythm (4.5+±0.2) to 100 (3.8±0.2, p<0.05, n=32) to 120 beats/min (3.2±0.1, p<0.05, n=7). Despite a 19±2 mm Hg rise in mean arterial pressure during handgrip exercise, CFR was unchanged from baseline (3.7±0.3 vs. 3.7±0.4, p=NS, n=7) because rCBFV rose proportionally with hCBFV. When pulmonary capillary wedge pressure was increased from 9±1 to 16±1 mm Hg after volume expansion, CFR was significantly decreased (from 3.8±0.2 to 2.9+±0.2, p<0.05, n=9) because rCBFV was increased while hCBFV remained unchanged. Hence, serial CFR measurements in humans are highly reproducible in the absence of conditions known to affect resting or hyperemic coronary blood flow. Increases in heart rate or preload reduced CFR because rCBFV was increased while hCBFV was unchanged. In contrast, changes in mean arterial pressure did not alter CFR. Proper interpretation of CFR measurements should take into account the hemodynamic conditions at which they are obtained. (Circulation 1990;81:1319-1330 The concept of coronary flow reserve, introduced 30 years ago by Coffman and Gregg,' provides a method for describing the capacity of the coronary circulation to conduct maximal hyperemic blood flow. The subsequent development
The concept of coronary flow reserve, introduced 30 years ago by Coffman and Gregg,'
provides a method for describing the capacity of the coronary circulation to conduct maximal hyperemic blood flow. The subsequent development of techniques for measuring coronary blood flow in humans (e.g., intracoronary Doppler catheter, digital subtraction angiographic methods, and thermodilution coronary sinus blood flow techniques) has enabled coronary flow reserve to be measured in a variety of disease states (e.g., atherosclerosis, infarction, hypertrophy, Syndrome X, and after cardiac transplantation). [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Previous studies have suggested that coronary flow reserve measurements can be used to evaluate coronary microvascular function '6-18 and to assess the physiological significance of epicardial coronary stenoses6 and that flow reserve measurements might be useful in assessing the need for revascularization in patients with coronary artery disease of intermediate severity. 20,2' In most studies, coronary flow reserve has been measured as a ratio of peak hyperemic coronary blood flow (after administration of a maximal coronary vasodilator such as papaverine or dipyridamole) to resting coronary blood flow. It has been hypothesized that changes in hemodynamic conditions, independent of changes in the function of the coronary circulation, might directly influence coronary flow reserve by altering resting or hyperemic blood flow.22-24 If human coronary flow reserve is influenced significantly by hemodynamic parameters, then it would be important to adjust the normal limits of coronary flow reserve to particular hemodynamic settings and to consider the effect of differences in hemodynamic conditions between sequential studies. Accordingly, this study was designed to examine the effect of changes in heart rate, arterial pressure, and left ventricular preload on coronary flow reserve and to define the long-term variability of coronary flow reserve measurements.
Methods

Patient Selection
Four study protocols were used to examine the interstudy variability of coronary flow reserve measurements and the effect of heart rate, arterial pressure, and left ventricular preload on coronary flow reserve. Individuals participating in these protocols were selected from two groups of patients.
Thirty-eight cardiac allograft recipients. Each heart transplant recipient underwent a routine annual invasive cardiac evaluation (coronary angiography, pulmonary artery catheterization, and right ventricular endomyocardial biopsy) for the purpose of screening for subacute-chronic allograft rejection. Posttransplantation immunosuppression was achieved in each patient with cyclosporine, azathioprine, and prednisone. None of the patients evaluated had an episode of acute rejection at any time after transplantation, and all had normal coronary arteries at angiography. Crosssectional and M-mode echocardiographic evaluations of left ventricular systolic performance, obtained 1 day before catheterization, were normal in each subject. Four patients had left ventricular hypertrophy, defined as diastolic septal or posterior wall thickness greater than 11 mm.
Five patients with normal coronary arteries and two with minimal coronary artery disease (<50% diameter stenosis by quantitative coronary angiography with the Brown et al25 method). Each patient underwent coronary angiography for the diagnosis of a chest pain syndrome. Left ventricular function, as assessed by contrast or equilibrium radionuclide ventriculography, was normal (left ventricular ejection fraction greater than 50% with no focal wall motion abnormality).
None of the patients from either group had the following conditions that might have affected the vasodilator capacity of the coronary vasculature: 1) historical or electrocardiographic evidence of myocardial infarction, defined by either clinical history of infarction associated with total serum creatine kinase elevation, increased creatine kinase-MB fraction, and After routine diagnostic coronary angiography was performed, maximal epicardial coronary artery vasodilation was produced with intracoronary nitroglycerin (300-600 ag). Heparin sodium (5-10,000 U i.v.) was administered to increase the activated clotting time to at least twice the control level. A 3F 20-mHz coronary Doppler catheter (NuMed, Hopkinton, New York) was then advanced through an 8F large lumen coronary guiding catheter into the proximal segment of a coronary artery. The catheter position and Doppler range gate were adjusted to obtain a high-quality tracing of phasic coronary blood flow velocity. Mean and phasic signals of coronary blood flow velocity (kilohertz shift), arterial pressure obtained through the guiding catheter, heart rate, and electrocardiogram were recorded continuously on a multichannel direct-writing recorder (Gould, Oxnard, California) . This technique has been previously described.2 Because the arterial waveform obtained from the guiding catheter was damped by the coronary Doppler catheter, only mean arterial pressure could be accurately monitored.
Before any intervention, baseline measurements of resting coronary blood flow velocity were obtained. To determine coronary flow reserve during resting hemodynamic conditions, 8-14 mg papaverine hydrochloride (2 mg/ml 0.9% saline) was injected through the guiding catheter into the coronary ostium, and the resultant increase in coronary blood flow velocity was recorded. To confirm that maximal hyperemia was produced in each patient, progressively larger doses of papaverine (increases of 2-4 mg/injection) were administered until coronary blood flow velocity was maximal. Blood flow velocity was allowed to return to baseline levels between doses of papaverine. We have previously demonstrated that, administered in this fashion, intracoronary papaverine produces maximal coronary hyperemia equal in magnitude to that caused by intravenous dipyridamole infusion. 26 Effect of left ventricular preload on coronary flow
reserve. The effect of ventricular preload on coronary flow reserve was studied in nine patients (seven heart transplant recipients and two normal subjects). Heart rate was held constant in six subjects by right atrial pacing at 100 beats/min. In the remaining three patients, heart rate in sinus rhythm was nearly 100 beats/min and changed 2% or less after left ventricular preload was increased. Phasic and mean coronary blood flow velocity, mean aortic and coronary pressures, heart rate, electrocardiogram, and pulmonary capillary wedge pressure were continuously monitored. After baseline coronary flow reserve was measured (five left anterior descending and four left circumflex coronary arteries), intravascular volume was expanded by rapid administration of warmed normal saline (600-1,000 ml/10 min i.v. To examine further the relation between heart rate and coronary flow reserve, hemodynamic and coronary blood flow velocity measurements were obtained during normal sinus rhythm and right atrial pacing at 100 beats/min in 32 patients ( Table 2) . As expected, when the heart rate was increased from sinus rhythm (76±2 beats/min) to 100 beats/min, coronary blood flow velocity increased significantly. Hyperemic coronary blood flow velocity, however, did not significantly change (Table 2, Figure 2 ). Consequently, coronary flow reserve measured during normal sinus rhythm (4.5±0.2) was significantly greater than flow reserve at a heart rate of 100 beats/min (3.8±0.2,p<0.05, Figure 3 ).
In seven of these patients, in whom serial flow reserve measurements were obtained during normal sinus rhythm and right atrial pacing at 100 and 120 Figure 6 ). Importantly, hyperemic and resting coronary blood flow velocities increased proportionally during handgrip so that their ratio, coronary flow reserve, was unchanged (3.7+0.3 at rest vs. 3.7±0.4 during handgrip, p=NS, Figure 6 ). Similarly, minimum coronary vascular resistance during handgrip also was not significantly different from baseline. Hence, maximal coronary flow reserve and an index of minimum coronary vascular resistance remained constant despite an average increase in mean arterial pressure of 19±2 mm Hg.
In response to isometric handgrip exercise, supine plasma arterial norepinephrine concentration was unchanged (235±35 at rest vs. 256±26 pg/ml at maximum handgrip, p=NS, n=12), suggesting that changes in humoral norepinephrine concentration could not have altered microcirculatory function. reserve is significantly heart rate dependent, the enced by pharmacological alterations of resting or exceptional long-term reproducibility of flow reserve maximal hyperemic coronary blood flow. Although measurements in these patients might have been medications with cardiac or vasoactive properties related, in part, to the absence of significant changes were discontinued at least 4 hours before the study, in heart rate between studies.
nine of the 17 patients in this protocol received Seventh, the interstudy variability of coronary flow long-term treatment for hypertension with calcium reserve measurements also might have been influchannel or f-adrenergic receptor antagonists that 
Previous Studies
In conscious humans3536 and dogs,37 tachycardia produced by cardiac pacing is associated with elevated myocardial oxygen demand and increased coronary blood flow. In awake dogs, maximal hyperemic coronary blood flow (produced by intravenous adenosine), however, remained constant as heart rate was increased to 200 beats/min and decreased significantly only at a heart rate of 250 beats/min.38 Consequently, coronary flow reserve was reduced during tachycardia primarily because of elevated resting coronary blood flow, although at very rapid heart rates, coronary arterial compressive forces accompanying mechanical ventricular systole and shortened diastolic coronary perfusion time might have significantly reduced hyperemic coronary blood flow. These studies parallel our observations in humans. Although there was a trend for hyperemic coronary blood flow velocity to be reduced at higher heart rates, it was not significant.
When the mean arterial pressure of dogs anesthetized with barbiturates was increased from 94±2 to 123±4 mm Hg by constriction of the descending thoracic aorta, resting and peak reactive hyperemic coronary blood flow rose proportionally with the increased coronary driving pressure.39 Within the zone of coronary autoregulation,40 coronary flow reserve remained constant, as we observed in humans. When arterial pressure in dogs was increased to levels at which autoregulation of coronary blood flow was lost (138±2 mm Hg), however, coronary flow reserve was reduced because resting coronary blood flow increased more than hyperemic coronary blood flow.39 Hence, although the results of our study in humans were similar to those performed in animals with an arterial pressure in the zone of coronary autoregulation, elevation of arterial pressure beyond the bounds of autoregulation might reduce maximal coronary reserve. In an open-chest, open-pericardium, anesthetized dog preparation in which coronary autoregulation was abolished with vasodilation (carbochromen or adenosine), increased left ventricular preload produced by volume expansion was associated with a reduction in the ratio of endocardial to epicardial coronary blood flow.4142 Total diastolic left circumflex coronary blood flow was either decreased41 or did not change.42 When heart rate and systemic perfusion rate were controlled in anesthetized, open-chest dogs, however, increased left ventricular volume was associated with increased left ventricular wall tension and myocardial oxygen demand. 43 Coronary blood flow increased in response to elevated left ventricular preload. The effect of increased left ventricular preload on total coronary blood flow in the conscious animal has not been studied. Our study suggests, however, that in the conscious human with an intact pericardium, rapid increases in left ventricular preload are associated with significant increases in resting coronary blood flow without a significant change in total peak hyperemic blood flow.
Implications
In the absence of significant changes in heart rate or ventricular preload, serial coronary flow reserve measurements (ratio of peak hyperemic to resting coronary blood flow velocity) are highly reproducible in humans. Hence, sequential determinations of coronary flow reserve obtained with a Doppler catheter can be a valuable clinical tool in the longitudinal assessment of the coronary circulation of conscious humans. Proper interpretation of both isolated and serial coronary flow reserve measurements, however, should take into account the hemodynamic conditions at which they are obtained. In our laboratory, we now obtain all coronary flow reserve measurements at a heart rate of 100 beats/min (atrial pacing). In this way, we can compare the results of serial measurements and assess the significance (normal vs. abnormal) of an isolated measurement. In heart transplant patients with normal coronary arteries and myocardium, the mean (±SD) coronary flow reserve at a heart rate of 100 beats/min is 4.0±1.1 (range, 3.0-7.5, n=25).
Many prior clinical studies have investigated the effects of pathological states,12-19 physiological stimuli,44 and coronary revascularization7-10 on coronary flow reserve. It is possible that hemodynamic alterations, rather than a process intrinsic to the condition or intervention being studied, caused some of the reported abnormalities of coronary flow reserve. Reduced coronary flow reserve in congestive cardiomyopathy, for example, might have been partly due to the direct effects on resting coronary blood flow of tachycardia and elevated left ventricular preload rather than an anatomic or functional abnormality that reduced maximal hyperemic blood flow in the coronary vasculature. The results of these studies and of future investigations should be examined with attention to the effect of heart rate and left ventricular preload on coronary flow reserve measurements.
